{
    "nctId": "NCT02944929",
    "officialTitle": "Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity (Repeated Botulinum Toxin Injections and Physiotherapy) on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke",
    "inclusionCriteria": "1. Males and females aged between 18 to 75 years.\n2. Adult patient under guardianship with consent obtained and the legal guardian's authorisation obtained.\n3. Single stroke having occurred more than 6 months before (previous TIA is accepted).\n4. Capable of understanding instructions and participating in the definition of a therapeutic goal (Boston Diagnostic Aphasia Examination (BDAE) \\< 3).\n5. Having previously undergone BTI. The last injection must have been performed at least 4 months prior to inclusion.\n6. Affiliation to the French social security regime or a similar regime.\n7. Patient (or the legal guardian if under guardian adult patient) has signed the informed consent form.\n* Must have minimum age of 18 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "1. Patients who are unwilling to participate in the study. For the one under guardianship, the refusal of the patient will be the final decision even if the guardian is willing to participate.\n2. Subjects who are unlikely to adhere to the study an/or poor adherence anticipated by the investigator.\n3. Un-controlled progressive pathology.\n4. Osteoarticular lesion which contraindicates part of the rehabilitation involved in the study.\n5. Patients with other interventions planned prior to the end of the study period (orthosis, surgery etc.).\n6. Surgery to the treated limb less than 6 months previously.\n7. Pregnant woman."
}